Chambers Global Practice Guide: Life Sciences & Pharma IP Litigation 2025 – Singapore chapter by Drew & Napier

05 Mar 2025

Managing Director of Intellectual Property Tony Yeo, Directors Meryl Koh, Rozalynne Asmali and Javier Yeo co-authored the Singapore chapter in the Chambers Global Practice Guide: Life Sciences & Pharma IP Litigation 2025.

The Life Sciences & Pharma IP Litigation 2025 guide covers the latest developments in patent litigation, generic and biosimilar market entry, patent term extensions, available forms of relief, other IP rights, appeal, ADR and settlement/antitrust considerations.

You may read the full chapter here.

Reproduced with permission from Chambers Global Practice Guides. This chapter was published in January 2025; contributing editor: Nicola Dagg from Kirkland & Ellis International LLP. For further information, please visit Chambers and Partners' website.